Cell Signaling and Feedback

Gregor Welcomes You!

Welcome back, investigators! Every cell in your body is listening — constantly monitoring its chemical environment for signals from neighboring cells, distant organs, and the outside world. Cell signaling is biology's communication network, and understanding it explains everything from how insulin controls blood sugar to how cancer cells escape normal growth controls. Let's investigate!

A single human body contains roughly 37 trillion cells, yet they behave as a coordinated whole. How? Through chemical signals — molecules released by one cell that alter the behavior of another. Cell signaling is the molecular language of multicellular life. It coordinates development, regulates metabolism, triggers immune responses, and controls the cell cycle. Disruptions to signaling pathways underlie virtually every major human disease, including cancer, diabetes, and autoimmune disorders.

Modes of Cell Communication

Before examining the machinery of signaling, it is useful to recognize that cells communicate over different distances using different modes:

Paracrine signaling — a cell secretes a signal that acts on nearby cells within the same tissue (e.g., growth factors, neurotransmitters at short range)
Autocrine signaling — a cell responds to signals it secretes itself (common in immune cells and cancer cells)
Endocrine signaling — signaling molecules (hormones) are released into the bloodstream and travel to distant target cells (e.g., insulin from the pancreas acting on muscle and liver)
Synaptic signaling — a specialized form of paracrine signaling in which neurons release neurotransmitters across synaptic clefts to postsynaptic cells

Regardless of the distance traveled, all signaling pathways share the same three-stage logic.

The Three Stages of Signal Transduction

Every cell signaling pathway can be described in three stages:

Reception — a signaling molecule (the ligand) binds to a specific receptor protein. The receptor may be on the cell surface or inside the cell, depending on whether the ligand can cross the plasma membrane.
Transduction — receptor binding triggers a series of molecular changes — a signal transduction pathway — that converts and amplifies the signal.
Response — the transduced signal ultimately alters cellular behavior: gene expression changes, enzyme activity shifts, ion channels open, or the cytoskeleton reorganizes.

Key Insight

Notice how this three-stage model connects to everything you already know. Reception depends on membrane proteins (Chapter 5). Transduction often involves phosphorylation by enzymes (Chapter 6). Responses can include changes in gene expression (Chapter 10 and 11). Cell signaling is the master coordinator that links these molecular mechanisms to whole-cell behavior.

Diagram: Signal Transduction Pathway Overview

View Fullscreen

Signal Transduction Pathway Overview — Specification

Type: MicroSim (p5.js)
sim-id: signal-transduction-pathway
Library: p5.js
Status: Specified

Learning objective: Students will be able to describe (Bloom's L2: Understand) the three stages of cell signaling — reception, transduction, response — and identify the role of each stage in a given pathway.

Canvas: 760 × 460 px, responsive.

Layout: Horizontal three-panel flow: Reception (left, blue) → Transduction (center, purple) → Response (right, green). Each panel has a title header, icon, and descriptive bullet list. Arrows between panels.

Reception panel: - Icon: key + lock symbol (ligand + receptor) - Labels: "Ligand (signal molecule)", "Receptor protein" - Text: "Specific binding triggers conformational change" - Dropdown selector: choose receptor type (GPCR / RTK / Ligand-gated ion channel / Intracellular) - Selection updates the center panel to show the appropriate transduction pathway

Transduction panel (changes based on receptor selection): - For GPCR: shows G-protein → adenylyl cyclase → cAMP → PKA chain - For RTK: shows dimerization → autophosphorylation → Ras → MAPK cascade - For ion channel: shows ion influx → downstream effects - For intracellular: shows receptor-ligand entering nucleus - Cascade steps shown as connected circles with molecule names and phosphorylation badges (P)

Response panel: - Options shown as checkboxes: Gene expression, Enzyme activation/inhibition, Ion channel opening, Cytoskeleton change, Cell division - Active responses highlighted based on receptor selection

Interaction: - Select receptor type from dropdown to update the transduction pathway - Click any molecule in the cascade to see a tooltip with its full name, type, and function - "Animate signal" button traces a glowing dot from ligand → receptor → cascade → response

Responsive design: Panel widths scale equally with container width; text scales proportionally.

Receptor Types and Ligand-Receptor Binding

The specificity of cell signaling depends on ligand-receptor binding — a lock-and-key complementarity between the signal molecule and its receptor protein. A ligand binds only to receptors with a matching binding site; this determines which cells respond to a given signal.

Binding characteristics: - Binding is reversible — ligand-receptor complexes can dissociate, allowing the signal to be turned off - Binding is non-covalent — hydrogen bonds, ionic interactions, and van der Waals forces - Affinity describes how tightly a ligand binds; high-affinity receptors respond to very low ligand concentrations

Receptors are divided into two broad classes based on the ligand's ability to cross the plasma membrane:

Receptor Class	Location	Ligand type	Examples
G protein-coupled receptors (GPCRs)	Cell surface	Hydrophilic (cannot cross membrane)	Epinephrine, glucagon, odorants
Receptor tyrosine kinases (RTKs)	Cell surface	Hydrophilic peptide/protein hormones	Insulin, EGF, PDGF
Ligand-gated ion channels	Cell surface	Neurotransmitters	Acetylcholine, GABA
Intracellular (nuclear) receptors	Cytoplasm/nucleus	Hydrophobic (cross membrane freely)	Steroid hormones, thyroid hormone

G Protein-Coupled Receptors (GPCRs)

G protein-coupled receptors are the largest family of cell-surface receptors in the human genome — over 800 genes encode GPCRs. They are seven-pass transmembrane proteins: the receptor protein threads through the lipid bilayer seven times, with the ligand-binding domain exposed to the extracellular space and the intracellular surface coupled to a G protein.

The G protein is a trimeric complex (Gα, Gβ, Gγ subunits) that acts as a molecular switch:

Inactive state: Gα has GDP bound; the trimer is associated with the inactive receptor.
Activation: Ligand binds → receptor changes conformation → Gα exchanges GDP for GTP → Gα dissociates from Gβγ → Gα-GTP activates downstream effectors (e.g., adenylyl cyclase).
Inactivation: Gα hydrolyzes GTP to GDP (intrinsic GTPase activity) → Gα returns to inactive state → G-protein reassembles.

When adenylyl cyclase is activated, it converts ATP to cyclic AMP (cAMP) — a second messenger that amplifies the signal inside the cell.

cAMP Signaling and Protein Kinase A

cAMP (cyclic adenosine monophosphate) is one of the most important second messengers in biology. It is synthesized from ATP by adenylyl cyclase and degraded by phosphodiesterase. Its concentration rises transiently after GPCR activation and returns to baseline when the signal ends.

cAMP activates protein kinase A (PKA) — an enzyme that phosphorylates serine and threonine residues on target proteins. PKA is normally inactive, held in check by regulatory subunits; when four cAMP molecules bind to the regulatory subunits, they release the active catalytic subunits. PKA then phosphorylates dozens of target proteins, each with a different cellular effect:

In liver cells: PKA activates glycogen phosphorylase (glycogen breakdown) and inhibits glycogen synthase (glycogen synthesis) — net effect: glucose is released into the blood
In heart muscle cells: PKA increases heart rate and contraction force
In fat cells: PKA activates lipase to mobilize fatty acids

This response to the hormone epinephrine (adrenaline) illustrates how a single GPCR-cAMP-PKA pathway can coordinate an organism-wide "fight or flight" response.

Diagram: cAMP Signaling Cascade

View Fullscreen

cAMP Signaling Cascade — Specification

Type: MicroSim (p5.js)
sim-id: camp-signaling-cascade
Library: p5.js
Status: Specified

Learning objective: Students will be able to trace (Bloom's L3: Apply) the sequence of molecular events from hormone binding to a GPCR through the cAMP-PKA cascade to a cellular response, and explain how signal amplification occurs at each step.

Canvas: 760 × 500 px, responsive.

Layout: Vertical cascade flow from top (extracellular ligand) to bottom (cellular response). Each molecule represented as a labeled circle or shape with color coding.

Cascade steps (top to bottom): 1. Epinephrine (ligand) — orange hexagon — "binds GPCR" 2. GPCR (7-pass receptor) — membrane-spanning rectangle — "activates G protein" 3. G protein (Gα-GTP) — purple oval — "GDP→GTP exchange; activates adenylyl cyclase" 4. Adenylyl cyclase — yellow diamond — "ATP → cAMP" 5. cAMP molecules — small blue circles (quantity increases) — "4 cAMP activate PKA" 6. PKA (active) — green pentagon — "phosphorylates target proteins" 7. Target proteins (×N) — multiple shapes — "enzyme activation or inhibition" 8. Cellular response — outcome box (e.g., "Glycogen breakdown, glucose release")

Amplification counter: A live counter shows how many product molecules are generated at each step. Starting with 1 epinephrine molecule, the counter shows ×1 → ×10 → ×100 → ×1000 as the signal progresses, illustrating cascade amplification.

Phosphodiesterase toggle: A "PDE active" button degrades cAMP (blue circles disappear) and shows PKA returning to inactive state — illustrating signal termination.

Interaction: - Step-through mode: "Next step" button advances the cascade one stage at a time - Continuous mode: "Animate" button runs the full cascade loop - Click any molecule for a tooltip with name, type, and function - Slider to adjust initial ligand concentration (1–100 molecules); amplification counter updates

Responsive design: All shapes and text scale proportionally with container width.

Receptor Tyrosine Kinases (RTKs)

Receptor tyrosine kinases are cell-surface receptors that are themselves enzymes — specifically, protein kinases that phosphorylate tyrosine residues. They are activated by protein growth factors such as insulin, epidermal growth factor (EGF), and platelet-derived growth factor (PDGF).

The RTK activation mechanism differs from GPCRs:

Ligand binding causes two RTK monomers to associate side by side (dimerization).
Autophosphorylation: Each RTK in the dimer phosphorylates tyrosine residues on its partner.
The phosphorylated tyrosines serve as docking sites for intracellular signaling proteins.
Docked proteins activate downstream cascades, most prominently the Ras/MAPK pathway:
Ras (a GTPase) is activated → activates a kinase cascade (MAP kinase kinase kinase → MAP kinase kinase → MAP kinase)
Activated MAPK enters the nucleus and phosphorylates transcription factors
Result: changes in gene expression, often promoting cell growth and division

Gregor's Tip

The AP exam frequently tests the distinction between GPCRs and RTKs. Key differences: GPCRs use a separate G protein and often act through second messengers (cAMP); RTKs are enzymes themselves (the receptor IS the kinase) and activate multiple downstream cascades simultaneously via phosphotyrosine docking sites. RTK mutations that cause constitutive activity are a major cause of cancer — this is a high-probability AP free-response topic.

Intracellular Receptors

Not all signaling molecules bind to cell-surface receptors. Hydrophobic ligands — including steroid hormones (estrogen, testosterone, cortisol, aldosterone), thyroid hormones, and retinoids — can diffuse directly through the lipid bilayer.

Inside the cell, these ligands bind to intracellular receptors (also called nuclear receptors):

The receptor-ligand complex translocates to the nucleus (or may already reside there)
In the nucleus, it functions as a transcription factor — binding to specific DNA sequences (hormone response elements) and directly regulating gene expression
Because they alter transcription, intracellular receptor responses are slower (hours) but longer-lasting than cell-surface receptor responses (seconds to minutes)

This is a fundamentally different transduction mechanism: no membrane receptor, no second messenger, no kinase cascade — just a ligand-receptor complex acting directly on DNA.

Second Messengers and Signal Amplification

Second messengers are small, rapidly diffusing intracellular molecules that relay and amplify a signal from a cell-surface receptor. The original extracellular signal molecule (hormone, growth factor) is the "first" messenger; the intracellular relay molecule is the "second."

Common second messengers:

cAMP — synthesized by adenylyl cyclase from ATP; activates PKA; degraded by phosphodiesterase
IP₃ (inositol trisphosphate) — produced from membrane phospholipids; triggers \(\ce{Ca^2+}\) release from the ER
DAG (diacylglycerol) — produced alongside IP₃; activates protein kinase C (PKC) at the membrane
\(\ce{Ca^2+}\) — acts as a second messenger itself; binds calmodulin and other sensor proteins; triggers muscle contraction, exocytosis, and enzyme activation

Signal amplification occurs because each activated molecule in the cascade can activate many downstream molecules. A single hormone molecule binding one GPCR can activate hundreds of G proteins; each G protein activates adenylyl cyclase for multiple cycles, producing thousands of cAMP molecules; each active PKA phosphorylates many targets. The result: one hormone molecule can ultimately trigger the production of millions of product molecules.

Common Mistake

Second messengers are not the same as receptors, and they are not the original signal molecules. cAMP is produced inside the cell in response to extracellular signals — it relays the signal but is not the signal itself. Also note that second messengers are small molecules, not proteins. On the AP exam, be careful to distinguish: extracellular signal (ligand/first messenger) → receptor → second messenger → effector protein.

Feedback Loops: Negative and Positive

Signal transduction pathways do not just relay signals — they are regulated by feedback loops that modulate the strength and duration of the response.

Negative Feedback

In a negative feedback loop, the response to a stimulus reduces the original stimulus, returning the system toward a set point. Negative feedback underlies homeostasis — the maintenance of stable internal conditions.

Examples: - Blood glucose regulation: High blood glucose → insulin secretion → glucose uptake by cells → blood glucose falls → insulin secretion decreases - Thermoregulation: Body temperature rises → hypothalamus activates cooling mechanisms (sweating, vasodilation) → temperature falls → cooling mechanisms deactivated - Receptor desensitization: Prolonged ligand binding → receptor phosphorylation → reduced response to continued signal (e.g., β-arrestin recruitment to GPCRs)

Positive Feedback

In a positive feedback loop, the response amplifies the original stimulus, driving the system further from baseline. Positive feedback is less common in homeostasis — it typically governs all-or-nothing "switches" and self-amplifying events.

Examples: - Action potential: Slight membrane depolarization → Na⁺ channels open → more depolarization → more channels open → full action potential fires (all-or-nothing) - Blood clotting: Injury → thrombin activates more thrombin → rapid clot formation - Childbirth (oxytocin): Uterine contractions → oxytocin release → stronger contractions → more oxytocin → delivery

Diagram: Feedback Loop Simulator

View Fullscreen

Feedback Loop Simulator — Specification

Type: MicroSim (p5.js)
sim-id: feedback-loop-simulator
Library: p5.js
Status: Specified

Learning objective: Students will be able to compare (Bloom's L4: Analyze) negative and positive feedback loops, predict how each type responds to a perturbation, and identify real biological examples of each.

Canvas: 760 × 480 px, responsive.

Layout: Left panel: loop diagram (circular arrow showing stimulus → detector → response → effector → stimulus). Right panel: time-series graph showing the variable over time.

Controls: - Toggle buttons: "Negative Feedback" / "Positive Feedback" - Dropdown: choose example (Negative: blood glucose, thermoregulation, enzyme inhibition; Positive: action potential, blood clotting, childbirth) - "Apply perturbation" button: introduces a step increase or decrease in the stimulus variable - "Reset" button: returns system to initial state

Negative feedback behavior: - Time graph shows an oscillating damped curve that returns to set point after perturbation - Loop diagram arrow labeled "dampens/opposes" - Color: blue (stabilizing)

Positive feedback behavior: - Time graph shows an exponential/sigmoidal curve that moves away from baseline and may plateau (all-or-nothing) - Loop diagram arrow labeled "amplifies/reinforces" - Color: orange (amplifying)

Labels on graph: Set point (horizontal dashed line), perturbation marker (vertical dashed line), response curve.

Interaction: - Selecting a different example redraws the graph with that system's characteristic dynamics - Hover over any point on the graph to see the system state at that time - Click on loop diagram nodes (stimulus, detector, response, effector) for explanatory tooltips

Responsive design: Graph and loop diagram scale proportionally with container width.

Feature	Negative Feedback	Positive Feedback
Effect on stimulus	Opposes / reduces it	Amplifies / reinforces it
System behavior	Stabilizing (returns to set point)	Destabilizing (drives to new state)
Biological role	Homeostasis, receptor adaptation	Developmental switches, rapid amplification
Examples	Blood glucose, thermoregulation	Action potential, blood clotting, childbirth
Outcome	Steady state maintained	All-or-nothing response

Apoptosis: Programmed Cell Death

Apoptosis is a precisely controlled form of cell death in which a cell dismantles itself in response to intracellular or extracellular signals. It is distinct from necrosis (uncontrolled death from damage): apoptosis proceeds via an ordered sequence of molecular events with no inflammatory response.

Apoptosis is essential for normal development (sculpting limb digits, eliminating neurons that fail to connect properly), immune function (deleting self-reactive T cells), and tumor suppression (eliminating cells with DNA damage that cannot be repaired).

The Caspase Cascade

The execution of apoptosis depends on caspases — a family of cysteine proteases that cleave target proteins at aspartate residues. Caspases exist as inactive precursors (procaspases); activation of initiator caspases triggers cleavage and activation of effector caspases, creating a self-amplifying caspase cascade.

Activated effector caspases: - Cleave cytoskeletal proteins → cell shrinkage and blebbing - Activate CAD (caspase-activated DNase) → DNA fragmentation into ~200 bp "ladder" fragments (a diagnostic hallmark of apoptosis) - Flip phosphatidylserine from the inner to the outer leaflet of the plasma membrane → "eat me" signal for macrophage phagocytosis

Intrinsic and Extrinsic Pathways

Feature	Intrinsic (mitochondrial) pathway	Extrinsic (death receptor) pathway
Trigger	Intracellular stress (DNA damage, oxidative stress, growth factor withdrawal)	Extracellular death ligands (FasL, TNF) binding death receptors
Key proteins	Bcl-2 family (anti-apoptotic: Bcl-2, Bcl-xL; pro-apoptotic: Bax, Bak)	Fas receptor (TNFR family), FADD adaptor
Central event	Cytochrome c released from mitochondria → apoptosome formation	DISC (death-inducing signaling complex) formation
Initiator caspase	Caspase-9	Caspase-8
Effector caspases	Caspase-3, -7	Caspase-3, -7

Bcl-2 proteins are a critical regulatory checkpoint: anti-apoptotic members (Bcl-2, Bcl-xL) block cytochrome c release; pro-apoptotic members (Bax, Bak) promote it. The balance between these proteins determines whether a stressed cell lives or dies — and mutations that overexpress Bcl-2 are found in many lymphomas, making cells resistant to apoptosis.

p53 — the "guardian of the genome" — is a transcription factor activated by DNA damage. It upregulates pro-apoptotic Bcl-2 family members, pushing damaged cells toward apoptosis. Mutations in p53 are present in over half of all human cancers, explaining why tumor cells fail to die when they should.

Excellent Work!

From the first ligand binding its receptor to the last caspase dismantling a cell, you have now traced the complete logic of cellular communication. Cell signaling connects molecular events to whole-organism physiology — and understanding it is the key to understanding how cancer arises, how hormones work, and how drugs are designed. Outstanding investigation, scientists!

Summary

Cell signaling proceeds through three universal stages:

Reception: Ligand binds a specific receptor (cell-surface for hydrophilic ligands; intracellular for hydrophobic ligands)
Transduction: Signal is relayed and amplified — through G proteins → cAMP → PKA (GPCRs), tyrosine autophosphorylation → Ras/MAPK (RTKs), or direct nuclear entry (intracellular receptors)
Response: Gene expression, enzyme activity, ion flux, or cytoskeletal reorganization

Second messengers (cAMP, IP₃, DAG, Ca²⁺) amplify cell-surface receptor signals intracellularly. Feedback loops — negative (homeostasis) and positive (amplification) — regulate signal intensity and duration. Apoptosis executes programmed cell death via caspase cascades triggered by the intrinsic (mitochondrial) or extrinsic (death receptor) pathway, serving as a critical checkpoint in development and tumor suppression.

Self-Check: Test Your Understanding

Question 1. A researcher treats cells with a drug that inhibits phosphodiesterase. What effect would this have on cAMP signaling?

Answer

Phosphodiesterase degrades cAMP. Inhibiting it would cause cAMP levels to remain elevated longer after a GPCR stimulus, prolonging PKA activation and extending the cellular response. This is the mechanism of caffeine (which weakly inhibits phosphodiesterase in some tissues) and some drugs used to treat heart failure and asthma.

Question 2. How does signal transduction through an intracellular (nuclear) receptor differ fundamentally from GPCR signaling?

Answer

Intracellular receptors bind lipophilic ligands that cross the plasma membrane; the receptor-ligand complex acts directly as a transcription factor in the nucleus, requiring no second messenger or kinase cascade. GPCR signaling uses a hydrophilic ligand that cannot cross the membrane, requiring a surface receptor, G protein, second messenger (cAMP), and kinase cascade to alter cell behavior. GPCR responses are faster (seconds–minutes); intracellular receptor responses are slower (hours) but involve transcription and long-lasting gene expression changes.

Question 3. A cancer cell has a mutation in the Ras gene that prevents GTP hydrolysis. Predict the effect on cell proliferation.

Answer

Normal Ras is active only transiently (while bound to GTP) and turns itself off by hydrolyzing GTP to GDP. A mutation blocking hydrolysis locks Ras in the permanently "on" state, continuously activating the MAPK proliferation cascade regardless of whether a growth factor is present. The cell will proliferate uncontrollably — this type of constitutively active Ras mutation is found in ~30% of all human cancers.

Question 4. Why is apoptosis considered beneficial to the organism rather than harmful?

Answer

Apoptosis is an ordered, controlled process that eliminates damaged, infected, or excess cells without inflammation. It is essential for normal development (digit formation, neural pruning), immune regulation (deletion of self-reactive T cells), and cancer suppression (elimination of cells with unrepaired DNA damage). Unlike necrosis, the cellular contents are packaged into apoptotic bodies and phagocytosed cleanly. Loss of apoptosis — not too much of it — is what drives cancer progression.